However, PRAME has been reported to be an independent prognostic factor in AML M3 with t(15;17) [16] and to be associated with longer overall survival, even in karyotypes with generally poor prognosis such as deletion of the long arm of chromosome 7 and monosomy 7 [54]. This evidence concerns the gene PRAME and acute myeloid leukemia.